| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.518 | 0.021 | 0.555 | GABA C receptor rho-3 antagonist | 0.544 0.016 CID_154699630 0.434 0.047 CID_129041023 0.422 0.052 CID_154699731 0.514 0.022 CID_154699716 0.486 0.03 CID_150636292 0.555 0.014 CID_54687473 | CID_54687473 | |
| 0.44 | 0.004 | 0.44 | Erythropoietin receptor agonist | 0.433 0.004 CID_154699630 0.149 0.008 CID_129041023 0.409 0.004 CID_154699731 0.414 0.004 CID_154699716 0.415 0.004 CID_150636292 0.303 0.005 CID_54687473 | ||
| 0.409 | 0.036 | 0.817 | Aryl hydrocarbon receptor agonist | 0.416 0.035 CID_154699630 0.415 0.035 CID_129041023 0.267 0.072 CID_154699731 0.313 0.057 CID_154699716 0.266 0.073 CID_150636292 0.817 0.005 CID_54687473 | CID_54687473 | |
| 0.409 | 0.041 | 0.425 | Immunomodulator | 0.378 0.051 CID_154699630 0.334 0.066 CID_129041023 0.421 0.038 CID_154699731 0.405 0.042 CID_154699716 0.425 0.037 CID_150636292 0.375 0.052 CID_54687473 | CID_150636292 | |
| 0.383 | 0.025 | 0.394 | Sigma receptor agonist | 0.394 0.023 CID_154699630 0.177 0.07 CID_129041023 0.323 0.035 CID_154699731 0.39 0.023 CID_154699716 0.293 0.04 CID_150636292 0.171 0.073 CID_54687473 | CID_154699630 | |
| 0.342 | 0.009 | 0.397 | Heat shock protein 90 alpha antagonist | 0.356 0.008 CID_154699630 0.38 0.006 CID_129041023 0.331 0.01 CID_154699731 0.39 0.005 CID_154699716 0.397 0.005 CID_150636292 0.278 0.018 CID_54687473 | CID_150636292 | |
| 0.378 | 0.063 | 0.378 | Thyroid hormone antagonist | 0.368 0.067 CID_154699630 0.325 0.083 CID_129041023 0.241 0.129 CID_154699731 0.347 0.075 CID_154699716 0.329 0.081 CID_150636292 0.338 0.078 CID_54687473 | ||
| 0.373 | 0.061 | 0.373 | Thyroid hormone beta antagonist | 0.361 0.065 CID_154699630 0.317 0.08 CID_129041023 0.239 0.125 CID_154699731 0.335 0.074 CID_154699716 0.321 0.079 CID_150636292 0.333 0.074 CID_54687473 | ||
| 0.345 | 0.046 | 0.372 | Hypoxia-inducible factor 1 alpha inhibitor | 0.372 0.038 CID_154699630 0.23 0.119 CID_129041023 0.314 0.059 CID_154699731 0.361 0.041 CID_154699716 0.346 0.046 CID_150636292 0.282 0.075 CID_54687473 | CID_154699630 | |
| 0.305 | 0.009 | 0.372 | Heat shock protein 90 antagonist | 0.315 0.008 CID_154699630 0.372 0.005 CID_129041023 0.341 0.006 CID_154699731 0.369 0.005 CID_154699716 0.367 0.005 CID_150636292 0.217 0.031 CID_54687473 | CID_129041023 | |
| 0.259 | 0.019 | 0.306 | NADPH oxidase inhibitor | 0.286 0.014 CID_154699630 0.282 0.015 CID_129041023 0.148 0.056 CID_154699731 0.213 0.03 CID_154699716 0.148 0.055 CID_150636292 0.306 0.012 CID_54687473 | CID_54687473 | |
| 0.342 | 0.104 | 0.458 | 15-Lipoxygenase inhibitor | 0.373 0.087 CID_154699630 0.288 0.139 CID_129041023 0.31 0.125 CID_154699731 0.304 0.13 CID_154699716 0.314 0.122 CID_150636292 0.458 0.051 CID_54687473 | CID_54687473 | |
| 0.321 | 0.093 | 0.36 | Prostaglandin dehydrogenase inhibitor | 0.324 0.092 CID_154699630 0.286 0.108 CID_129041023 0.253 0.125 CID_154699731 0.307 0.099 CID_154699716 0.36 0.079 CID_150636292 0.274 0.115 CID_54687473 | CID_150636292 | |
| 0.267 | 0.043 | 0.267 | Anesthetic general | 0.25 0.05 CID_154699630 0.159 0.104 CID_129041023 0.187 0.082 CID_154699731 0.184 0.084 CID_154699716 0.168 0.096 CID_150636292 0.151 0.113 CID_54687473 | ||
| 0.298 | 0.08 | 0.436 | Streptokinase A inhibitor | 0.297 0.08 CID_154699630 0.253 0.101 CID_129041023 0.363 0.058 CID_154699731 0.257 0.098 CID_154699716 0.205 0.13 CID_150636292 0.436 0.038 CID_54687473 | CID_54687473 | |
| 0.283 | 0.102 | 0.309 | Cholesterol antagonist | 0.285 0.101 CID_154699630 0.231 0.139 CID_154699731 0.206 0.16 CID_154699716 0.194 0.17 CID_150636292 0.309 0.086 CID_54687473 | CID_54687473 | |
| 0.249 | 0.083 | 0.313 | Aldehyde oxidase inhibitor | 0.313 0.063 CID_154699630 0.294 0.068 CID_129041023 0.215 0.097 CID_154699731 0.185 0.113 CID_154699716 0.207 0.101 CID_150636292 0.189 0.111 CID_54687473 | CID_154699630 | |
| 0.235 | 0.071 | 0.254 | Neuropeptide Y2 antagonist | 0.245 0.061 CID_154699630 0.254 0.053 CID_129041023 0.185 0.148 CID_154699731 0.202 0.116 CID_154699716 0.202 0.115 CID_150636292 0.194 0.131 CID_54687473 | CID_129041023 | |
| 0.188 | 0.029 | 0.288 | Glutamate receptor antagonist | 0.185 0.031 CID_154699630 0.288 0.011 CID_129041023 0.159 0.045 CID_154699731 0.179 0.033 CID_154699716 0.138 0.059 CID_150636292 0.224 0.02 CID_54687473 | CID_129041023 | |
| 0.242 | 0.089 | 0.242 | 5 Hydroxytryptamine uptake stimulant | 0.226 0.109 CID_154699630 0.219 0.118 CID_129041023 0.233 0.099 CID_154699731 0.188 0.177 CID_154699716 0.219 0.119 CID_150636292 0.226 0.109 CID_54687473 | ||
| 0.145 | 0.005 | 0.245 | Plasminogen activator inhibitor antagonist | 0.138 0.005 CID_154699630 0.179 0.005 CID_129041023 0.122 0.007 CID_154699731 0.122 0.007 CID_154699716 0.13 0.006 CID_150636292 0.245 0.004 CID_54687473 | CID_54687473 | |
| 0.177 | 0.044 | 0.183 | GABA C receptor rho-2 antagonist | 0.183 0.04 CID_154699630 0.157 0.065 CID_129041023 0.132 0.102 CID_154699731 0.175 0.046 CID_154699716 0.161 0.06 CID_150636292 0.176 0.045 CID_54687473 | CID_154699630 | |
| 0.134 | 0.004 | 0.165 | Protocollagen prolyl hydroxylase inhibitor | 0.123 0.004 CID_154699630 0.096 0.004 CID_129041023 0.135 0.004 CID_154699731 0.126 0.004 CID_154699716 0.118 0.004 CID_150636292 0.165 0.003 CID_54687473 | CID_54687473 | |
| 0.232 | 0.103 | 0.269 | Gastrin inhibitor | 0.207 0.139 CID_154699630 0.191 0.162 CID_154699716 0.205 0.141 CID_150636292 0.269 0.059 CID_54687473 | CID_54687473 | |
| 0.122 | 0.014 | 0.131 | HIV-1 integrase inhibitor | 0.119 0.016 CID_154699630 0.096 0.027 CID_129041023 0.131 0.012 CID_154699731 0.116 0.017 CID_154699716 0.121 0.015 CID_150636292 0.128 0.013 CID_54687473 | CID_154699731 | |
| 0.211 | 0.118 | 0.245 | Tyrosine 3 hydroxylase inhibitor | 0.228 0.093 CID_154699630 0.245 0.073 CID_129041023 0.198 0.139 CID_154699731 0.204 0.128 CID_154699716 0.216 0.109 CID_150636292 0.195 0.144 CID_54687473 | CID_129041023 | |
| 0.182 | 0.091 | 0.242 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.191 0.08 CID_154699630 0.216 0.06 CID_129041023 0.242 0.046 CID_154699731 0.18 0.092 CID_154699716 0.176 0.098 CID_150636292 0.182 0.09 CID_54687473 | CID_154699731 | |
| 0.103 | 0.012 | 0.405 | NMDA 2A receptor antagonist | 0.113 0.01 CID_154699630 0.405 0.003 CID_129041023 0.07 0.024 CID_154699731 0.088 0.017 CID_154699716 0.053 0.035 CID_150636292 0.096 0.014 CID_54687473 | CID_129041023 | |
| 0.195 | 0.106 | 0.244 | RNA-directed DNA polymerase inhibitor | 0.185 0.124 CID_154699630 0.244 0.053 CID_129041023 0.173 0.146 CID_154699731 0.185 0.123 CID_154699716 0.243 0.054 CID_54687473 | CID_129041023 | |
| 0.163 | 0.078 | 0.197 | Catenin beta inhibitor | 0.172 0.062 CID_154699630 0.162 0.08 CID_129041023 0.142 0.126 CID_154699731 0.156 0.091 CID_154699716 0.141 0.129 CID_150636292 0.197 0.034 CID_54687473 | CID_54687473 | |
| 0.167 | 0.084 | 0.191 | Amyloid beta precursor protein antagonist | 0.172 0.079 CID_154699630 0.145 0.107 CID_154699731 0.158 0.093 CID_154699716 0.191 0.064 CID_54687473 | CID_54687473 | |
| 0.26 | 0.185 | 0.353 | DNA directed DNA polymerase inhibitor | 0.261 0.185 CID_154699630 0.238 0.199 CID_129041023 0.353 0.137 CID_54687473 | CID_54687473 | |
| 0.099 | 0.025 | 0.117 | Estrogen-related receptor beta agonist | 0.109 0.016 CID_154699630 0.092 0.037 CID_129041023 0.103 0.021 CID_154699731 0.117 0.011 CID_154699716 0.103 0.021 CID_150636292 | CID_154699716 | |
| 0.084 | 0.011 | 0.183 | NMDA receptor subunit 3A antagonist | 0.087 0.01 CID_154699630 0.183 0.004 CID_129041023 0.082 0.011 CID_154699731 0.072 0.014 CID_154699716 0.076 0.013 CID_150636292 0.076 0.012 CID_54687473 | CID_129041023 | |
| 0.193 | 0.125 | 0.193 | Cardiotonic | 0.181 0.138 CID_154699630 0.184 0.135 CID_154699731 0.189 0.13 CID_154699716 0.179 0.141 CID_150636292 | ||
| 0.179 | 0.115 | 0.204 | Antiamyloidogenic | 0.198 0.101 CID_154699630 0.204 0.097 CID_154699731 0.185 0.11 CID_154699716 | CID_154699731 | |
| 0.229 | 0.167 | 0.229 | Beta lactamase inhibitor | 0.2 0.185 CID_154699630 | ||
| 0.252 | 0.191 | 0.328 | DNA polymerase beta inhibitor | 0.257 0.188 CID_154699630 0.233 0.203 CID_129041023 0.328 0.15 CID_54687473 | CID_54687473 | |
| 0.078 | 0.019 | 0.078 | Corticotropin releasing factor 2 receptor antagonist | 0.066 0.035 CID_154699630 0.071 0.026 CID_129041023 0.066 0.035 CID_154699731 0.069 0.03 CID_154699716 0.062 0.042 CID_54687473 | ||
| 0.093 | 0.033 | 0.11 | T cell inhibitor | 0.089 0.039 CID_154699630 0.083 0.055 CID_129041023 0.084 0.051 CID_154699731 0.084 0.052 CID_154699716 0.11 0.018 CID_150636292 0.11 0.018 CID_54687473 | CID_54687473 | |
| 0.155 | 0.098 | 0.16 | Lipocortins synthesis antagonist | 0.139 0.123 CID_154699630 0.16 0.092 CID_129041023 0.138 0.125 CID_154699731 0.138 0.125 CID_154699716 0.146 0.111 CID_150636292 | CID_129041023 | |
| 0.213 | 0.161 | 0.221 | Thioredoxin glutathione reductase inhibitor | 0.204 0.169 CID_154699630 0.19 0.181 CID_129041023 0.221 0.155 CID_154699731 0.205 0.168 CID_150636292 0.215 0.159 CID_54687473 | CID_154699731 | |
| 0.075 | 0.027 | 0.087 | Androgen agonist | 0.076 0.026 CID_154699630 0.081 0.023 CID_129041023 0.082 0.023 CID_154699716 0.087 0.02 CID_150636292 0.053 0.052 CID_54687473 | CID_150636292 | |
| 0.158 | 0.109 | 0.181 | Psychostimulant | 0.151 0.115 CID_154699630 0.181 0.092 CID_154699731 0.148 0.118 CID_154699716 | CID_154699731 | |
| 0.128 | 0.086 | 0.142 | Farnesoid X receptor antagonist | 0.139 0.067 CID_154699630 0.131 0.081 CID_129041023 0.117 0.111 CID_154699731 0.142 0.062 CID_154699716 | CID_154699716 | |
| 0.057 | 0.017 | 0.057 | Benzodiazepine antagonist | 0.054 0.02 CID_154699630 0.054 0.02 CID_129041023 0.051 0.024 CID_154699731 0.049 0.028 CID_154699716 | ||
| 0.065 | 0.026 | 0.088 | Cannabinoid CB2 receptor antagonist | 0.054 0.034 CID_154699630 0.049 0.038 CID_129041023 0.06 0.03 CID_154699731 0.088 0.018 CID_54687473 | CID_54687473 | |
| 0.089 | 0.055 | 0.346 | NMDA receptor antagonist | 0.104 0.045 CID_154699630 0.346 0.005 CID_129041023 0.079 0.067 CID_154699731 0.08 0.065 CID_154699716 0.113 0.039 CID_54687473 | CID_129041023 | |
| 0.048 | 0.015 | 0.05 | Aggrecanase 1 inhibitor | 0.047 0.016 CID_154699630 0.05 0.014 CID_129041023 0.047 0.016 CID_154699731 0.044 0.019 CID_154699716 0.044 0.019 CID_150636292 | CID_129041023 | |
| 0.085 | 0.054 | 0.129 | D-Ala-D-Ala ligase inhibitor | 0.089 0.046 CID_154699630 0.085 0.056 CID_129041023 0.078 0.074 CID_154699731 0.081 0.067 CID_150636292 0.129 0.01 CID_54687473 | CID_54687473 | |
| 0.21 | 0.179 | 0.21 | Calpain 2 inhibitor | 0.202 0.186 CID_154699630 | ||
| 0.192 | 0.161 | 0.335 | 12-Lipoxygenase inhibitor | 0.211 0.139 CID_154699630 0.209 0.142 CID_154699731 0.335 0.063 CID_54687473 | CID_54687473 | |
| 0.135 | 0.105 | 0.17 | Mcl-1 antagonist | 0.136 0.105 CID_154699630 0.143 0.097 CID_129041023 0.17 0.074 CID_54687473 | CID_54687473 | |
| 0.046 | 0.023 | 0.052 | Liver X receptor alpha agonist | 0.052 0.018 CID_154699630 0.04 0.03 CID_154699731 0.039 0.031 CID_154699716 | CID_154699630 | |
| 0.035 | 0.012 | 0.037 | Liver X receptor alpha antagonist | 0.037 0.011 CID_154699630 0.027 0.024 CID_129041023 0.031 0.017 CID_154699731 0.034 0.014 CID_154699716 0.035 0.013 CID_150636292 | CID_154699630 | |
| 0.09 | 0.073 | 0.112 | Bile acid receptor antagonist | 0.094 0.064 CID_154699630 0.086 0.085 CID_129041023 0.092 0.068 CID_154699716 0.112 0.028 CID_54687473 | CID_54687473 | |
| 0.035 | 0.017 | 0.037 | Liver X receptor antagonist | 0.037 0.016 CID_154699630 0.03 0.023 CID_154699731 0.033 0.02 CID_154699716 0.034 0.018 CID_150636292 | CID_154699630 | |
| 0.045 | 0.028 | 0.047 | Liver X receptor agonist | 0.046 0.027 CID_154699630 0.039 0.037 CID_154699731 0.047 0.026 CID_154699716 0.042 0.033 CID_150636292 | CID_154699716 | |
| 0.179 | 0.165 | 0.235 | Lipoxygenase inhibitor | 0.196 0.145 CID_154699630 0.235 0.11 CID_54687473 | CID_54687473 | |
| 0.094 | 0.083 | 0.209 | Cystathionine beta-synthase inhibitor | 0.112 0.065 CID_154699630 0.11 0.066 CID_150636292 0.209 0.022 CID_54687473 | CID_54687473 | |
| 0.029 | 0.02 | 0.034 | Liver X receptor beta antagonist | 0.034 0.016 CID_154699630 0.026 0.022 CID_150636292 | CID_154699630 | |
| 0.074 | 0.069 | 0.088 | MAP kinase 7 inhibitor | 0.076 0.06 CID_154699716 0.088 0.023 CID_54687473 | CID_54687473 | |
| 0.012 | 0.009 | 0.014 | Egl nine homolog 2 inhibitor | 0.014 0.006 CID_54687473 | CID_54687473 | |
| 0.123 | 0.121 | 0.141 | Pregnane X receptor agonist | 0.13 0.1 CID_129041023 0.141 0.072 CID_54687473 | CID_54687473 | |
| 0.051 | 0.05 | 0.089 | Fatty acid synthase inhibitor | 0.051 0.05 CID_154699630 0.089 0.014 CID_129041023 0.055 0.042 CID_154699716 | CID_129041023 | |
| 0.063 | 0.062 | 0.069 | Benzodiazepine agonist | 0.069 0.052 CID_54687473 | CID_54687473 | |
| 0.158 | 0.159 | 0.222 | ErbB-1 antagonist | 0.163 0.147 CID_154699630 0.222 0.069 CID_129041023 0.185 0.108 CID_154699716 0.176 0.123 CID_54687473 | CID_129041023 | |
| 0.079 | 0.08 | 0.096 | Bromodomain-containing protein 2 inhibitor | 0.096 0.045 CID_54687473 | CID_54687473 | |
| 0.027 | 0.034 | 0.031 | Liver X receptor beta agonist | 0.031 0.027 CID_154699716 | CID_154699716 | |
| 0.041 | 0.048 | 0.05 | Bromodomain-containing protein 3 inhibitor | 0.05 0.034 CID_54687473 | CID_54687473 | |
| 0.111 | 0.119 | 0.115 | Mannose-6-phosphate isomerase inhibitor | 0.115 0.11 CID_54687473 | CID_54687473 | |
| 0.025 | 0.033 | 0.028 | Estrogen-related receptor gamma antagonist | 0.028 0.022 CID_154699630 | CID_154699630 | |
| 0.01 | 0.019 | 0.014 | Egl nine homolog 1 inhibitor | 0.014 0.011 CID_54687473 | CID_54687473 | |
| 0.096 | 0.105 | 0.15 | Interleukin 2 antagonist | 0.15 0.018 CID_54687473 | CID_54687473 | |
| 0.015 | 0.025 | 0.018 | Estrogen-related receptor gamma agonist | 0.017 0.016 CID_154699630 0.018 0.015 CID_154699716 | CID_154699716 | |
| 0.025 | 0.036 | 0.034 | Progesterone antagonist | 0.034 0.026 CID_150636292 | CID_150636292 | |
| 0.057 | 0.067 | 0.077 | Cannabinoid receptor antagonist | 0.077 0.043 CID_54687473 | CID_54687473 | |
| 0.142 | 0.153 | 0.254 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.202 0.099 CID_129041023 0.182 0.112 CID_154699731 0.151 0.141 CID_150636292 0.254 0.077 CID_54687473 | CID_54687473 | |
| 0.058 | 0.07 | 0.063 | Glutamate (mGluR7) antagonist | 0.063 0.058 CID_54687473 | CID_54687473 | |
| 0.078 | 0.091 | 0.096 | Creatine kinase inhibitor | 0.096 0.064 CID_154699630 0.093 0.068 CID_154699716 | CID_154699630 | |
| 0.056 | 0.068 | 0.311 | NMDA 2 receptor antagonist | 0.07 0.051 CID_154699630 0.311 0.005 CID_129041023 0.074 0.048 CID_54687473 | CID_129041023 | |
| 0.043 | 0.057 | 0.059 | Antiviral (Hepatitis D) | 0.059 0.023 CID_129041023 | CID_129041023 | |
| 0.126 | 0.14 | 0.294 | Pyruvate kinase inhibitor | 0.142 0.123 CID_154699630 0.144 0.12 CID_129041023 0.294 0.049 CID_54687473 | CID_54687473 | |
| 0.033 | 0.048 | 0.082 | NMDA receptor subunit 3B antagonist | 0.082 0.013 CID_129041023 0.049 0.026 CID_54687473 | CID_129041023 | |
| 0.067 | 0.082 | 0.078 | Androgen antagonist | 0.078 0.068 CID_129041023 0.076 0.071 CID_150636292 0.075 0.072 CID_54687473 | CID_129041023 | |
| 0.07 | 0.087 | 0.196 | Potassium channel (Ca-activated) activator | 0.081 0.075 CID_129041023 0.085 0.069 CID_154699731 0.196 0.015 CID_54687473 | CID_54687473 | |
| 0.109 | 0.127 | 0.118 | Sphingosine 1-phosphate receptor 2 antagonist | 0.118 0.103 CID_54687473 | CID_54687473 | |
| 0.049 | 0.068 | 0.075 | Heat shock protein 90 beta antagonist | 0.06 0.039 CID_129041023 0.064 0.034 CID_154699716 0.059 0.041 CID_150636292 0.075 0.024 CID_54687473 | CID_54687473 | |
| 0.025 | 0.045 | 0.032 | GHS receptor antagonist | 0.032 0.022 CID_129041023 | CID_129041023 | |
| 0.027 | 0.05 | 0.034 | Protein kinase (CK2) beta inhibitor | 0.034 0.022 CID_54687473 | CID_54687473 | |
| 0.153 | 0.178 | 0.166 | 5 Hydroxytryptamine release stimulant | 0.166 0.158 CID_129041023 | CID_129041023 | |
| 0.015 | 0.043 | 0.029 | Dopamine D1 agonist | 0.029 0.009 CID_150636292 | CID_150636292 | |
| 0.121 | 0.152 | 0.213 | MAP kinase kinase 2 inhibitor | 0.184 0.093 CID_129041023 0.213 0.074 CID_54687473 | CID_54687473 | |
| 0.018 | 0.05 | 0.025 | Thyroid hormone agonist | 0.025 0.02 CID_129041023 | CID_129041023 | |
| 0.047 | 0.085 | 0.064 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.064 0.036 CID_54687473 | CID_54687473 | |
| 0.079 | 0.118 | 0.097 | GABA C receptor antagonist | 0.097 0.082 CID_129041023 | CID_129041023 | |
| 0.047 | 0.087 | 0.137 | Prostaglandin-E synthase inhibitor | 0.086 0.035 CID_129041023 0.137 0.014 CID_54687473 | CID_54687473 | |
| 0.095 | 0.135 | 0.26 | Peroxidase inhibitor | 0.113 0.107 CID_154699630 0.26 0.045 CID_129041023 0.14 0.084 CID_150636292 0.139 0.084 CID_54687473 | CID_129041023 | |
| 0.011 | 0.053 | 0.054 | NMDA receptor glycine site antagonist | 0.054 0.005 CID_129041023 0.033 0.011 CID_54687473 | CID_129041023 | |
| 0.072 | 0.114 | 0.105 | MAP kinase kinase 1 inhibitor | 0.087 0.075 CID_154699716 0.105 0.05 CID_54687473 | CID_54687473 | |
| 0.072 | 0.115 | 0.103 | Potassium channel (Voltage-sensitive) activator | 0.103 0.049 CID_54687473 | CID_54687473 | |
| 0.038 | 0.086 | 0.081 | Dopamine agonist | 0.065 0.048 CID_129041023 0.081 0.037 CID_150636292 | CID_150636292 | |
| 0.048 | 0.1 | 0.083 | Potassium channel large-conductance Ca-activated activator | 0.063 0.053 CID_154699731 0.083 0.033 CID_54687473 | CID_54687473 | |
| 0.122 | 0.175 | 0.142 | Succinate dehydrogenase inhibitor | 0.139 0.135 CID_129041023 0.142 0.128 CID_54687473 | CID_54687473 | |
| 0.182 | 0.235 | 0.246 | Alpha-glucosidase inhibitor | 0.219 0.207 CID_154699630 0.214 0.21 CID_129041023 0.246 0.19 CID_54687473 | CID_54687473 | |
| 0.125 | 0.178 | 0.163 | Neurotensin receptor agonist | 0.163 0.075 CID_129041023 | CID_129041023 | |
| 0.119 | 0.173 | 0.157 | ATPase inhibitor | 0.153 0.096 CID_129041023 0.157 0.09 CID_54687473 | CID_54687473 | |
| 0.173 | 0.228 | 0.2 | Sodium/bile acid cotransporter inhibitor | 0.2 0.188 CID_154699630 | CID_154699630 | |
| 0.076 | 0.133 | 0.153 | MAP kinase kinase inhibitor | 0.115 0.079 CID_154699716 0.153 0.05 CID_54687473 | CID_54687473 | |
| 0.101 | 0.157 | 0.123 | Arachidonic acid antagonist | 0.123 0.122 CID_54687473 | CID_54687473 | |
| 0.146 | 0.204 | 0.178 | Peptidyltransferase inhibitor | 0.174 0.139 CID_129041023 0.178 0.132 CID_54687473 | CID_54687473 | |
| 0.151 | 0.209 | 0.237 | Nitric-oxide synthase stimulant | 0.237 0.042 CID_129041023 0.228 0.051 CID_54687473 | CID_129041023 | |
| 0.055 | 0.114 | 0.092 | Glycine receptor antagonist | 0.092 0.041 CID_129041023 | CID_129041023 | |
| 0.074 | 0.132 | 0.108 | Protein kinase C gamma inhibitor | 0.108 0.065 CID_54687473 | CID_54687473 | |
| 0.064 | 0.123 | 0.08 | NADH dehydrogenase inhibitor | 0.08 0.074 CID_129041023 | CID_129041023 | |
| 0.073 | 0.133 | 0.152 | Beta glucuronidase inhibitor | 0.152 0.024 CID_129041023 0.097 0.074 CID_54687473 | CID_129041023 | |
| 0.183 | 0.244 | 0.235 | Transcription factor inhibitor | 0.235 0.198 CID_54687473 | CID_54687473 | |
| 0.042 | 0.105 | 0.071 | Polo-like kinase-2 inhibitor | 0.071 0.052 CID_54687473 | CID_54687473 | |
| 0.098 | 0.162 | 0.189 | Amyloid beta aggregation inhibitor | 0.189 0.084 CID_154699731 | CID_154699731 | |
| 0.204 | 0.268 | 0.252 | Apoptosis agonist | 0.252 0.212 CID_129041023 | CID_129041023 | |
| 0.092 | 0.157 | 0.149 | Diuretic | 0.149 0.078 CID_54687473 | CID_54687473 | |
| 0.031 | 0.098 | 0.099 | NMDA receptor glycine site agonist | 0.099 0.017 CID_129041023 0.097 0.018 CID_54687473 | CID_129041023 | |
| 0.01 | 0.079 | 0.025 | CXC chemokine 2 receptor antagonist | 0.025 0.021 CID_129041023 0.025 0.021 CID_54687473 | CID_54687473 | |
| 0.172 | 0.243 | 0.213 | Interleukin 2 agonist | 0.213 0.168 CID_54687473 | CID_54687473 | |
| 0.054 | 0.125 | 0.065 | MDM2 inhibitor | 0.065 0.057 CID_54687473 | CID_54687473 | |
| 0.03 | 0.102 | 0.059 | 5 Hydroxytryptamine 3 antagonist | 0.059 0.037 CID_54687473 | CID_54687473 | |
| 0.066 | 0.138 | 0.106 | Chelator | 0.106 0.07 CID_154699731 | CID_154699731 | |
| 0.02 | 0.093 | 0.077 | Phosphorylase inhibitor | 0.077 0.018 CID_54687473 | CID_54687473 | |
| 0.012 | 0.09 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.023 0.01 CID_129041023 | CID_129041023 | |
| 0.037 | 0.123 | 0.086 | NMDA receptor agonist | 0.086 0.025 CID_129041023 0.069 0.037 CID_54687473 | CID_129041023 | |
| 0.063 | 0.149 | 0.108 | GABA receptor agonist | 0.108 0.068 CID_54687473 | CID_54687473 | |
| 0.114 | 0.2 | 0.217 | Interleukin agonist | 0.217 0.105 CID_54687473 | CID_54687473 | |
| 0.03 | 0.117 | 0.079 | TRPA1 antagonist | 0.079 0.026 CID_54687473 | CID_54687473 | |
| 0.099 | 0.186 | 0.154 | Dual specificity phosphatase inhibitor | 0.128 0.124 CID_154699731 0.154 0.09 CID_54687473 | CID_54687473 | |
| 0.062 | 0.151 | 0.094 | Protein kinase C zeta inhibitor | 0.094 0.059 CID_54687473 | CID_54687473 | |
| 0.059 | 0.149 | 0.107 | Ferrochelatase inhibitor | 0.107 0.064 CID_54687473 | CID_54687473 | |
| 0.071 | 0.161 | 0.127 | Hedgehog signaling inhibitor | 0.127 0.035 CID_54687473 | CID_54687473 | |
| 0.108 | 0.201 | 0.12 | CC chemokine 6 receptor antagonist | 0.12 0.119 CID_54687473 | CID_54687473 | |
| 0.02 | 0.115 | 0.052 | Thymidylate synthase inhibitor | 0.052 0.024 CID_129041023 | CID_129041023 | |
| 0.023 | 0.121 | 0.079 | NMDA 2C receptor antagonist | 0.079 0.025 CID_129041023 | CID_129041023 | |
| 0.12 | 0.218 | 0.154 | Cyclic AMP phosphodiesterase inhibitor | 0.154 0.145 CID_129041023 | CID_129041023 | |
| 0.161 | 0.263 | 0.353 | Histamine release inhibitor | 0.353 0.098 CID_54687473 | CID_54687473 | |
| 0.116 | 0.218 | 0.142 | Heat shock protein 70 antagonist | 0.142 0.069 CID_54687473 | CID_54687473 | |
| 0.149 | 0.256 | 0.223 | Immunosuppressant | 0.223 0.173 CID_150636292 | CID_150636292 | |
| 0.056 | 0.166 | 0.133 | 5 Hydroxytryptamine 3A agonist | 0.133 0.046 CID_54687473 | CID_54687473 | |
| 0.052 | 0.162 | 0.078 | GABA B receptor agonist | 0.078 0.046 CID_129041023 | CID_129041023 | |
| 0.064 | 0.174 | 0.12 | Caspase 3 inhibitor | 0.12 0.061 CID_54687473 | CID_54687473 | |
| 0.113 | 0.224 | 0.215 | Death-associated protein kinase 2 inhibitor | 0.215 0.025 CID_129041023 0.167 0.073 CID_54687473 | CID_129041023 | |
| 0.069 | 0.182 | 0.104 | TRPA1 agonist | 0.104 0.08 CID_54687473 | CID_54687473 | |
| 0.018 | 0.132 | 0.036 | Integrin alpha2 antagonist | 0.036 0.027 CID_54687473 | CID_54687473 | |
| 0.028 | 0.142 | 0.056 | CXC chemokine 1 receptor antagonist | 0.056 0.027 CID_54687473 | CID_54687473 | |
| 0.033 | 0.152 | 0.071 | Purinergic P2X1 antagonist | 0.071 0.031 CID_54687473 | CID_54687473 | |
| 0.085 | 0.216 | 0.163 | Polo-like kinase-3 inhibitor | 0.163 0.071 CID_54687473 | CID_54687473 | |
| 0.054 | 0.186 | 0.085 | DNA directed RNA polymerase inhibitor | 0.085 0.077 CID_129041023 | CID_129041023 | |
| 0.137 | 0.27 | 0.222 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.222 0.133 CID_129041023 0.211 0.145 CID_54687473 | CID_129041023 | |
| 0.045 | 0.188 | 0.087 | HIV-1 integrase (Overall Integration) inhibitor | 0.087 0.068 CID_54687473 | CID_54687473 | |
| 0.116 | 0.261 | 0.191 | MAP-kinase-activated kinase 5 inhibitor | 0.186 0.123 CID_129041023 0.191 0.115 CID_54687473 | CID_54687473 | |
| 0.051 | 0.199 | 0.113 | Estrogen receptor beta antagonist | 0.09 0.083 CID_154699630 0.095 0.073 CID_154699716 0.113 0.042 CID_150636292 | CID_150636292 | |
| 0.121 | 0.27 | 0.192 | Transcription factor STAT3 inhibitor | 0.192 0.145 CID_54687473 | CID_54687473 | |
| 0.051 | 0.203 | 0.094 | Polo-like kinase-1 inhibitor | 0.094 0.054 CID_54687473 | CID_54687473 | |
| 0.029 | 0.184 | 0.059 | Cyclin B3 inhibitor | 0.059 0.057 CID_129041023 | CID_129041023 | |
| 0.208 | 0.365 | 0.41 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.326 0.18 CID_129041023 0.41 0.092 CID_54687473 | CID_54687473 | |
| 0.039 | 0.2 | 0.099 | Urease inhibitor | 0.099 0.068 CID_129041023 | CID_129041023 | |
| 0.05 | 0.216 | 0.113 | AMP-activated protein kinase stimulant | 0.099 0.072 CID_129041023 0.113 0.056 CID_54687473 | CID_54687473 | |
| 0.068 | 0.236 | 0.13 | Dual specificity phosphatase 3 inhibitor | 0.13 0.116 CID_54687473 | CID_54687473 | |
| 0.099 | 0.278 | 0.216 | 5 Hydroxytryptamine 1E antagonist | 0.216 0.113 CID_54687473 | CID_54687473 | |
| 0.119 | 0.302 | 0.197 | Transcription factor STAT inhibitor | 0.197 0.142 CID_54687473 | CID_54687473 | |
| 0.056 | 0.246 | 0.115 | Estrogen antagonist | 0.103 0.09 CID_154699716 0.115 0.064 CID_150636292 | CID_150636292 | |
| 0.029 | 0.224 | 0.061 | Aryl hydrocarbon receptor antagonist | 0.061 0.051 CID_54687473 | CID_54687473 | |
| 0.101 | 0.301 | 0.174 | Cyclin-dependent kinase 3 inhibitor | 0.174 0.055 CID_129041023 | CID_129041023 | |
| 0.086 | 0.287 | 0.146 | Neurotrophic factor enhancer | 0.146 0.144 CID_54687473 | CID_54687473 | |
| 0.02 | 0.234 | 0.047 | Purinergic P2X4 antagonist | 0.047 0.03 CID_54687473 | CID_54687473 | |
| 0.162 | 0.38 | 0.336 | 5 Hydroxytryptamine release inhibitor | 0.308 0.156 CID_129041023 0.336 0.128 CID_54687473 | CID_54687473 | |
| 0.018 | 0.244 | 0.045 | Carnitine palmitoyltransferase 1B inhibitor | 0.045 0.039 CID_54687473 | CID_54687473 | |
| 0.009 | 0.256 | 0.047 | Cathepsin L2 inhibitor | 0.047 0.024 CID_154699731 | CID_154699731 | |
| 0.06 | 0.309 | 0.169 | Hexokinase inhibitor | 0.169 0.059 CID_54687473 | CID_54687473 | |
| 0.155 | 0.404 | 0.252 | Caspase 9 stimulant | 0.252 0.251 CID_54687473 | CID_54687473 | |
| 0.074 | 0.325 | 0.141 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.141 0.091 CID_129041023 | CID_129041023 | |
| 0.056 | 0.315 | 0.119 | Aurora-C kinase inhibitor | 0.119 0.108 CID_129041023 | CID_129041023 | |
| 0.057 | 0.326 | 0.118 | Sphingosine 1-phosphate receptor 4 antagonist | 0.118 0.077 CID_54687473 | CID_54687473 | |
| 0.016 | 0.361 | 0.069 | Nav1.8 sodium channel blocker | 0.069 0.057 CID_54687473 | CID_54687473 | |
| 0.122 | 0.473 | 0.252 | MAP kinase kinase 6 inhibitor | 0.252 0.187 CID_54687473 | CID_54687473 | |
| 0.122 | 0.499 | 0.266 | Calcium channel L-type activator | 0.266 0.188 CID_129041023 | CID_129041023 | |
| 0.066 | 0.484 | 0.127 | Death-associated protein kinase 1 inhibitor | 0.127 0.091 CID_54687473 | CID_54687473 | |
| 0.078 | 0.57 | 0.16 | MAP kinase kinase 5 inhibitor | 0.16 0.114 CID_129041023 | CID_129041023 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |